iBio
IBIO
#9818
Rank
NZ$80.23 M
Marketcap
NZ$3.57
Share price
4.43%
Change (1 day)
-14.55%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2025 (TTM): NZ-$2.63

According to iBio's latest financial reports the company's current EPS (TTM) is NZ-$2.66. In 2024 the company made an earnings per share (EPS) of NZ-$11.22 an increase over its 2023 EPS that were of NZ-$183.24.

EPS history for iBio from 2007 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$2.63-76.55%
2024NZ-$11.22-93.88%
2023NZ-$183.24-8.14%
2022NZ-$199.4892.67%
2021NZ-$103.54-80.33%
2020NZ-$526.31-35.11%
2019NZ-$811.03-38.96%
2018NZ-$1,329-6.1%
2017NZ-$1,41536.67%
2016NZ-$1,03533.33%
2015NZ-$776.5250%
2014NZ-$517.68-53.85%
2013NZ-$1,122-7.14%
2012NZ-$1,208-64.1%
2011NZ-$3,36577.27%
2010NZ-$1,898144.44%
2009NZ-$776.5212.93%
2008NZ-$687.6312.2%
2007NZ-$612.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Genocea Biosciences
GNCA
NZ-$0.90-66.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.43-191.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.01-777.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
NZ-$13.75 417.53%๐Ÿ‡บ๐Ÿ‡ธ USA